INTRODUCTION
============

Chagas disease is an anthropozoonosis caused by *Trypanosoma cruzi*, a flagellate protozoan[@B09] that infects approximately 12-14 million people in Latin America[@B15]. After contact with the parasite, patients develop the acute phase of the illness, which may be asymptomatic in some individuals or may show non-specific symptoms, such as fever, tachycardia, weakness, and lymphadenopathy. This evolves into an indeterminate phase, with no clinical signs, but with subclinical pathologies[@B17]. Many years after infection, about 30% of the patients develop the chronic phase of the disease, which has characteristic signs including megaesophagus, megacolon and cardiomegaly[@B24]. During the chronic phase, the presence of microfoci parasites leads to the constant production of interleukin-12, which activates macrophages and generates a Th1 immune response consistent with delayed hypersensitivity, which leads to tissue damage[@B14] ^,^ [@B24].

Much of the damage to the host in Chagas disease is caused by an excess of free radicals, more specifically by the metabolism of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These are produced by phagocytic cells stimulated by inflammatory mediators in tissues parasitized by *T. cruzi*. They may harm any cellular component, but the components that are affected most strongly are the cellular membranes[@B18] ^,^ [@B23] ^,^ [@B42] ^,^ [@B43].

To combat the formation of free radicals and neutralize them before they cause damage, biological systems use molecules and enzymes such as reduced glutathione (GSH), superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px), and vitamin E. Others, such as vitamin C (ascorbic acid), glutathione reductase (GSH-Rd), and glutathione peroxidase (GSH-Px) are used to repair damage that has already been done[@B42].

A study by WEYERS *et al.* [@B44] showed that appropriate doses of vitamin C can have a preventive effect against the lipid peroxidation induced by free radicals; both those formed naturally and those caused by exogenous compounds in mice experimentally dosed with the antibacterial drug ciprofloxacin. Vitamin C decreased the oxidative stress on the liver and lipid peroxidation in the mouse kidney caused by this drug[@B43]. According to MAY[@B33], ascorbic acid\'s ability to reduce oxidative stress would depend on its concentration and its potential for recycling in blood and endothelium.

However researches of CHEN *et al.* [@B11] showed that pharmacological doses of ascorbic acid favored the cytotoxicity of tumor cells by formation of hydrogen peroxide (H~2~O~2~), leading to the decreased growth of tumors in mice due to pro-oxidant action. For LEVINE *et al.* [@B29] ascorbate could be used as a treatment for viral and bacterial infections and in other human pathogens, where the production of H~2~O~2~ and ROS could be beneficial in disease progression.

A study by MAÇAO *et al.* [@B30] showed that oxidative stress was controlled in the myocardium of patients in the chronic phase of Chagas disease when 500 mg of vitamin C and 800 UI of vitamin E were administered daily for a six-month period, probably as a consequence of vitamin E consumption and antioxidant protection. According to KOURY & DONANGELO[@B28], vitamins C and E are important \"street sweepers\" of free radicals.

Nonetheless, CHEN[@B10] noted that with a lower concentration of vitamin E, the administration of high doses of vitamin C appears to promote lipid peroxidation and significantly decreases the animals\' antioxidant potential.

Based on these studies, the authors decided to investigate the effectiveness of vitamin C in combating the oxidative insult caused by progressive *T. cruzi*inflammation during the evolution of Chagas disease in its chronic phase, by administering two different daily dosages of vitamin C to mice experimentally infected with the *T. cruzi* QM1strain, since the common sense of its role in antioxidant defense makes its use indiscriminate among people, including chronic carriers of Chagas disease.

MATERIALS AND METHODS
=====================

**Infection of mice:** Thirty 20-day-old male \"Swiss\" mice, weighing on average 13 grams, were intraperitoneally infected with 5.0 × 10[@B04] trypomastigotes of *T. cruzi* QM1 strain[@B32] via blood from other previously-infected mice, which was obtained by cardiac puncture into heparin. The trypomastigotes were counted following the BRENER[@B06] method and the intraperitoneal infection was performed by inoculating 0.1 mL of blood using an Injex® insulin syringe. Following this procedure, three groups of 10 mice were chosen at random and named P (placebo), Vit C 60 (mice that received the dose of vitamin C (D60); see next section for the doses given), and Vit C 500 (mice that received a dosage of vitamin C (D500)). The animals were kept in individual cages to facilitate handling and fed with the standard Nuvilab CR-1® diet, which is composed of: ground whole corn, soybean meal, wheat bran, calcium carbonate, calcium phosphate, sodium chloride, vegetable fat, mineral vitamin premix, amino acid, and water *ad libitum*.

**Calculation of vitamin C dosage and treatment:** Vit C 60 group (a D60 dose) was given a daily dose of 60 mg of vitamin C, equal to the average weight of the mice × (8.6 × 10-[@B04] mg per gram of weight), diluted in 10 μL of human mineral water (Soft®). Vit C 500 group (a D500 dose) was given a daily dose of 500 mg of vitamin C, equal to the average weight of the mice × (7.14 × 10-[@B03] mg per gram of weight) diluted in 10 μL of human mineral water (Soft®). The P group was a placebo group: each animal received 10 μL of human mineral water (Soft®) daily. Every morning, all mice were treated orally with 10 μL of vitamin C (D60 or D500) in mineral water or mineral water (Soft®) alone, using a Gilson automatic pipette. The three groups were treated for 180 days, starting from the infection date. Vitamin C used in this research was Cewin® (in drops doses) from Sanifi-Aventis Laboratory.

**Histopathologic analysis:** A fragment of heart, colon and skeletal thigh muscle from all mice that survived was collected on the 180^th^ day after infection for histopathologic analysis after CO~2~ euthanasia[@B22]. The tissues were embedded in paraffin and 5 μm sections were stained with hematoxylin-eosin and examined under a light microscope at a magnification of 400×. Five sequential histological sections were examined for each fragment, and the fragments were analyzed and graded for inflammation and amastigote nests for a total of 10 high magnification fields for each type of tissue. The investigator examining the sections was unaware of the grouping of the mice.

A semi-quantitative scale of one to three plus signs was used in order to grade the inflammatory process and the number of amastigote nests. This way, inflammation and/or necrosis were examined separately to the number of amastigotes for each animal: \"+\" signified mild inflammation, necrosis and rare amastigote nests; \"++\" moderate inflammation, necrosis and moderate number of amastigote nests; and \"+++\", intense inflammation, necrosis and frequent amastigote nests.

**Biochemistry:** Blood samples were collected on the 180^th^ day after infection. The mice were exposed to CO~2~ (100% CO~2~) for a few seconds as a form of anesthetizing them, and then the blood was collected by cardiac puncture into heparin. This method of euthanasia was chosen as studies conducted by GODIN & GARNETT[@B22] and BILLERT & DROBNICK[@B05]show that exposure to this gas may not increase oxidative damage to tissues.

Blood was centrifuged at 1500 g immediately after collection and the plasma stored at -80 ºC. For the measurement of vitamin C, 200 µL plasma samples were immediately acidified with 800 µL 5% trichloroacetic acid and stored at -80 ºC for later analysis. One fragment of heart muscle from each mouse was immediately frozen in liquid nitrogen and subsequently stored at -80 ºC. Oxidative stress markers were determined around 3 - 5 weeks after sampling. All samples were stored at -80 ºC before analysis.

Thiobarbituric acid reactive substances (TBARS) were used as biomarkers of lipid peroxidation in plasma and heart muscle and measured using a method adapted from COSTA *et al.* [@B13]. The total concentration of TBARS was determined by the difference in absorbance between samples and in a standard solution of malondialdehyde. The total peroxide in the cardiac muscle and plasma was determined using the FOX method, as described by SÖDERGREN *et al.* [@B38]. This method uses a comparison with the standard curve of H~2~O~2~. Quantification of plasma glutathione was performed by adapting the method described by COSTA *et al.* [@B13] using the standard curve of GSH.

The vitamin C concentration in plasma and heart muscle was determined according to BESSEY\'s[@B04] method, 100 µL of a solution containing 2,4-dinitrophenylhydrazine (2%), thiourea (5%), and copper sulfate (0.6%) in sulfuric acid (25%) added to 300 µL of acidified plasma. After a 4-hour incubation in a 37 ºC water bath, 200 µL sulfuric acid (65%) was added and the solution was incubated for 20 min at room temperature. Reading was performed on a spectrophotometer (Spectramax M5, Molecular Devices) at 520 nm and compared with the standard curve of vitamin C.

**Statistics:** The results were analyzed by Normality Test (Shapiro-Wilks) to verify that the data followed a normal distribution and homogeneity of variances in the groups of Levene\'s test. Statistical inference was performed using ANOVA one-way and Post-hoc analyses were performed with the Tukey (HSD) test[@B01]. The significance level used was 5%.

This study was approved by the Ethics Committee of the Faculty of Medicine of Marília (FAMEMA) under number 133/10. The manner of treatment, care, and euthanasia of mice followed the standards set by Colégio Brasileiro de Experimentação Animal/Brazilian College of Animal Experimentation (Cobea)[@B39].

RESULTS
=======

After 180 days of treatment two animals had died in the placebo group, three had died in group Vit C 60, and four had died in group Vit C 500. The study was therefore performed on eight animals in group P, seven in group Vit C 60, and six in group Vit C 500. Group Vit C 500 suffered greater damage to the skeletal muscle, showing a greater degree of inflammation than group Vit C 60 and a greater degree of necrosis than group P ([Table 1](#t01){ref-type="table"}). With regards to cardiac muscle and the colon, all animals in group Vit C 500 had inflammation, with mice of this group showing a greater level of damage.

###### Degree of histopathologic lesions and parasitism in mice infected by *T. cruzi* QM1 and treated with two different doses of vitamin C (VitC60= D60; VitC500= D500) and placebo (P): (+) mild inflammation, necrosis and rare amastigote nests; (++) moderate inflammation, necrosis and moderate number of amastigote nests; (+++) intense inflammation, necrosis and frequent amastigote nests. \* \"%\"; indicates the percentage of infected mice affected by necrosis or inflammation in each group, and the absolute number observed is given in parentheses

                    P                       VitC60                  VitC500                                                                       
  ----------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----- ----------
  Skeletal muscle   \+          12.5% (1)   ---         50.0% (4)               ---         ---         42.6% (3)               50.0% (3)   ---   100% (6)
  ++                ---         ---         ---                     ---         ---         14.3% (1)               ---         ---         ---   
  +++               ---         ---         ---                     ---         ---         ---                     ---         ---         ---   
  Cardiac muscle    \+          50.0% (4)   12.5% (1)   ---                     85.7% (6)   ---         ---                     50.0% (3)   ---   ---
  ++                25.0% (2)   ---         ---                     ---         ---         ---                     50.0% (3)   ---         ---   
  +++               ---         ---         ---                     ---         ---         ---                     ---         ---         ---   
  Colon             \+          62.5% (5)   ---         ---                     42.9% (3)   28.6% (2)   ---                     50.0% (3)   ---   ---
  ++                25.0% (2)   ---         ---                     28.6% (2)   ---         ---                     50.0% (3)   ---         ---   
  +++               ---         ---         ---                     ---         ---         ---                     ---         ---         ---   

An analysis of TBARS, total peroxide, vitamin C, and plasma GSH is shown in [Table 2](#t02){ref-type="table"} and an analysis of TBARS, total peroxide and vitamin C in the myocardium is shown in [Table 3](#t03){ref-type="table"}. Group P had lower total peroxide concentrations in plasma than group Vit C 500 (*p* = 0.021, [Table 2](#t02){ref-type="table"}). The TBARS analysis in plasma showed a statistically significant difference between group P and group Vit C 500 (*p* = 0.021, [Table 2](#t02){ref-type="table"}), and between group Vit C 60 and group Vit C 500 (*p* = 0.022, [Table 2](#t02){ref-type="table"}). There was no statistically significant difference between the groups in the plasma GSH (*p* \> 0.05, [Table 2](#t02){ref-type="table"}).

###### Mean values and standard deviation of thiobarbituric acid reactive substances (TBARS), total peroxide, vitamin C and reduced glutathione (GSH) in plasma of mice treated with two different doses of vitamin C (VitC60= D60; VitC500= D500) and placebo (P) during the chronic phase of experimental infection by *T. cruzi* QM1. (SD = standard deviation)

  *Variable*                                         *P*                   *VitC60*              *VitC500*             *Compared Groups*
  -------------------------------------------------- --------------------- --------------------- --------------------- -------------------
  **TBARS (μmol/L)**                                 34.8 (SD = 2.5)       34.8 (SD = 2.8)       41.0 (SD = 6.1)       P & VitC60
  P & VitC500[\*](#TFN01){ref-type="table-fn"}                                                                         
  VitC60 &VitC500[\*](#TFN01){ref-type="table-fn"}                                                                     
  **Total peroxide (μmol H~2~O~2~equivalent/L)**     88.4 (SD = 35.2)      134.3 (SD = 38.1)     148.6 (SD = 40.0)     P & VitC60
  P & VitC500[\*](#TFN01){ref-type="table-fn"}                                                                         
  VitC60 & VitC500                                                                                                     
  **Vitamin C (mg/dL)**                              0.28 (SD = 0.07)      0.29 (SD = 0.07)      0.33 (SD = 0.04)      P & VitC60
  P & VitC500                                                                                                          
  VitC60 & VitC500                                                                                                     
  **GSH (mmol/L)**                                   237.13 (SD = 29.45)   203.30 (SD = 46.77)   183.32 (SD = 25.59)   P & VitC60
  P & VitC500                                                                                                          
  VitC60 & VitC500                                                                                                     

Groups differ by Tukey test at 5% probability.

There was a higher total production of peroxides in the myocardium of group Vit C 500 than in group P (*p* = 0.050, [Table 3](#t03){ref-type="table"}). TBARS analysis (lipid oxidation levels) in the myocardium showed no statistically significant differences between the dosages.

###### Mean values and standard deviation of thiobarbituric acid reactive substances (TBARS), total peroxide and vitamin C in the myocardium of mice treated with two different doses of vitamin C (VitC60= D60; VitC500= D500) and placebo (P) during the chronic phase of experimental infection by *T. cruzi* QM1. (SD = standard deviation)

  *Variables*                                               *P*                 *VitC60*             *VitC500*            *Compared Groups*
  --------------------------------------------------------- ------------------- -------------------- -------------------- -------------------
  **TBARS (μmol/g protein)**                                82.4 (SD = 20.3)    73.6 (SD = 14.3)     100.4 (SD = 27.1)    P & VitC60
  P & VitC500                                                                                                             
  VitC60 &VitC500                                                                                                         
  **Total peroxide (μmol H~2~O~2~ equivalent/g protein)**   161.4 (SD = 82.3)   304.1 (SD = 172.7)   368.4 (SD = 188.6)   P & VitC60
  P & VitC500[\*](#TFN02){ref-type="table-fn"}                                                                            
  VitC60 &VitC500                                                                                                         
  **Vitamin C (μg/g prot)**                                 6.61 (SD = 1.13)    6.76 (SD = 0.74)     6.97 (SD = 0.76)     P & VitC60
  P & VitC500                                                                                                             
  VitC60 &VitC500                                                                                                         

Groups differ by Tukey test at 5% probability.

The vitamin C results showed no statistical differences in plasma and myocardium between the three groups with *p* \> 0.05 for all comparisons.

DISCUSSION
==========

To date, no research has been done to test the effectiveness of vitamin C in combating ROS and RNS produced during the evolution of Chagas disease. This study has shown that oral administration of 500 mg of vitamin C, per 180 days, in mice infected with *T. cruzi* can be harmful to the host, leading to increased total peroxide and TBARS, which may increase the severity of lesions, characteristic of chronic phase of this disease.

In this study, the vitamin C doses of 60 mg and 500 mg provided to groups Vit C 60 and Vit C 500 resulted in no statistically significant differences in myocardial and plasma vitamin C concentrations relative to group P (*p* \> 0.05 in all comparisons). The absence of differences between experimental groups in these results at the time of plasma and tissue collection could be explained by the physiological mechanism of control of concentrations of vitamin C, where ascorbate concentrations in plasma and tissue are tightly controlled. According to LEVINE *et al.* [@B29], the vitamin C concentration was tightly controlled by absorption, tissue transport and renal reabsorption and excretion.

Surprisingly, the dosage of 500 mg caused detrimental repercussions to the host. This is confirmed by the study\'s results regarding the number of mice that survived the treatment and the histopathologic findings, in which group Vit C 500 was shown to have suffered greater skeletal, cardiac muscle and colonic tissue damage, causing the death of a large number of animals.

Corroborating the histopathologic findings, a greater total peroxide production in group Vit C 500 than in group P was observed, both in plasma (*p* = 0.021) and in the myocardium (*p* = 0.050), as well as an increase in plasma TBARS concentrations in group Vit C 500 (*p* = 0.021). Although a tendency of decrease in GSH concentration of group Vit C 500 was observed, suggesting that antioxidant response was activated to neutralize ROS and RNS during disease progression, these results were not statistically significant.

Researches of MAÇAO *et al.* [@B30] demonstrated a decrease in TBARS and increase in GSH when chronic chagasic patients were supplemented daily with 500 mg vitamin C and 800 IU vitamin E. The effectiveness of these antioxidants has been studied by various authors[@B03] ^,^ [@B46], who indicated that both vitamins C and E operate in the context of an integrated system in which the overall antioxidant status is under homeostatic control, so that the change in status of a single antioxidant may affect the status of the other in a way that the ratio C/E can be of central importance to antioxidant protection[@B21].

Nevertheless, the aim of this study was to evaluate the effects of the isolated uses of ascorbic acid. These results show that daily supplementation, only with the equivalent of 500 mg of vitamin C, is coupled with a statistically significant increase in production of free radicals and lipid peroxidation between Vit C 60 Vit C 500 (*p* = 0.022), as shown by the result.

Although the antioxidant properties of vitamin C are well established[@B02] ^,^ [@B20] ^,^ [@B26], it is still debatable that it beholds a possible pro-oxidant[@B08] ^,^ [@B16] ^,^ [@B37] and an anti / pro-inflammatory effect[@B27] ^,^ [@B34].

*In vitro* studies performed by CLEMENT *et al.* [@B12], showed that, in high concentrations, vitamin C can exert a pro-oxidant effect before antioxidant, but *in vivo* the biological relevance of these events remains controversial[@B08].

However, in case of an injury inflicted by these tissues, the possibility of free transition metal Fe^3+^ and Cu^2+^ increases, which may be reduced by ascorbate[@B07]. *In vitro*, the interaction of these reduced metals with H~2~O~2~ produce hydroxyl radicals and lipid alkoxyl radicals (LO·), causing oxidative damage, and the ascorbate would then act as pro oxidant.

Therefore, it is possible that a high intake of vitamin C could be harmful to persons who have chronic inflammatory conditions[@B19], because it would cause the interaction of these catalytically active metals with ascorbate, as in the chronic phase of Chagas disease. This would also cause damage to surrounding tissues, which contribute to the inflammatory process, besides the fact that their own ROS amplify the release of pro-inflammatory cytokines.

Although several studies in humans and other species delineate the functional significance of vitamin C in resistance to infection[@B40] ^,^ [@B41], the effects of a high dose on the activity of the immune system is still scarce.

Studies of HORNIG *et al.* [@B25] reported the increased bioavailability of nitric oxide in patients with chronic heart failure after arterial and oral administration of vitamin C and NOH *et al.* [@B36], discovered that megadoses of vitamin C increased the production of interferon, IL-2 and TNF-α, showing a positive correlation between serum levels of vitamin C and pro inflammatory cytokines. Moreover, MIKIROVA *et al.* [@B34] discovered that high doses of vitamin C reduces inflammation in patients with cancer.

These results showed an increase in the inflammatory process with the presence of vitamin C and, in a high dosage, an exacerbation of tissue damage. This infers that, in the chronic phase of Chagas disease, the administration of 500 mg of vitamin C provides a pro-oxidant and pro-inflammatory medium to these animals. Since the effects were not observed in shorter periods of supplementation[@B31], these results may indicate the potential risk of for patients at the chronic phase of Chagas disease in ingesting high vitamin C concentrations for a long period of time. These results will be elucidated through future research on the technique of immunohistochemistry and may highlight whether the exacerbation of the inflammatory process is associated with the presence of the parasite or its cell debris, or if it occurred due to the actions of vitamin C.

Therefore, these results indicate the need for further investigation to elucidate the mechanisms whereby the high dosage of vitamin C may operate in the parasite[@B35] ^,^ [@B45] or in the harmful events identified by this research.
